vs
BRC Inc.（BRCC）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
BRC Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.5倍（$112.7M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 6.5%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $-9.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 7.0%）
BRC Inc.是一家美国高端咖啡与生活方式品牌，主营烘焙咖啡豆、即饮咖啡饮品、品牌服饰及户外装备，核心客群包含退伍军人、急救人员与户外爱好者，在北美地区通过电商及线下实体门店渠道销售产品。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
BRCC vs PBYI — 直观对比
营收规模更大
BRCC
是对方的1.5倍
$75.5M
营收增速更快
PBYI
高出21.2%
6.5%
自由现金流更多
PBYI
多$23.8M
$-9.4M
两年增速更快
PBYI
近两年复合增速
7.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $112.7M | $75.5M |
| 净利润 | $-3.2M | — |
| 毛利率 | 32.1% | 69.3% |
| 营业利润率 | -6.3% | 22.7% |
| 净利率 | -2.8% | — |
| 营收同比 | 6.5% | 27.7% |
| 净利润同比 | -29.3% | — |
| 每股收益（稀释后） | $-0.02 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BRCCPBYI
| Q4 25 | $112.7M | $75.5M | ||
| Q3 25 | $100.7M | $54.5M | ||
| Q2 25 | $94.8M | $52.4M | ||
| Q1 25 | $90.0M | $46.0M | ||
| Q4 24 | $105.9M | $59.1M | ||
| Q3 24 | $98.2M | $80.5M | ||
| Q2 24 | $89.0M | $47.1M | ||
| Q1 24 | $98.4M | $43.8M |
净利润BRCCPBYI
| Q4 25 | $-3.2M | — | ||
| Q3 25 | $-486.0K | $8.8M | ||
| Q2 25 | $-5.3M | $5.9M | ||
| Q1 25 | $-2.9M | $3.0M | ||
| Q4 24 | $-2.5M | — | ||
| Q3 24 | $-535.0K | $20.3M | ||
| Q2 24 | $-482.0K | $-4.5M | ||
| Q1 24 | $548.0K | $-4.8M |
毛利率BRCCPBYI
| Q4 25 | 32.1% | 69.3% | ||
| Q3 25 | 36.9% | 77.7% | ||
| Q2 25 | 33.9% | 76.5% | ||
| Q1 25 | 36.1% | 77.1% | ||
| Q4 24 | 38.1% | 76.4% | ||
| Q3 24 | 42.1% | 63.9% | ||
| Q2 24 | 41.9% | 77.4% | ||
| Q1 24 | 42.9% | 75.5% |
营业利润率BRCCPBYI
| Q4 25 | -6.3% | 22.7% | ||
| Q3 25 | 0.5% | 17.6% | ||
| Q2 25 | -13.3% | 12.7% | ||
| Q1 25 | -6.0% | 8.7% | ||
| Q4 24 | -2.1% | 22.6% | ||
| Q3 24 | 1.1% | 27.4% | ||
| Q2 24 | 1.1% | -4.6% | ||
| Q1 24 | 4.0% | -5.3% |
净利率BRCCPBYI
| Q4 25 | -2.8% | — | ||
| Q3 25 | -0.5% | 16.2% | ||
| Q2 25 | -5.6% | 11.2% | ||
| Q1 25 | -3.2% | 6.5% | ||
| Q4 24 | -2.3% | — | ||
| Q3 24 | -0.5% | 25.2% | ||
| Q2 24 | -0.5% | -9.6% | ||
| Q1 24 | 0.6% | -11.0% |
每股收益（稀释后）BRCCPBYI
| Q4 25 | $-0.02 | $0.26 | ||
| Q3 25 | $0.00 | $0.17 | ||
| Q2 25 | $-0.07 | $0.12 | ||
| Q1 25 | $-0.04 | $0.06 | ||
| Q4 24 | $-0.03 | $0.40 | ||
| Q3 24 | $-0.01 | $0.41 | ||
| Q2 24 | $-0.01 | $-0.09 | ||
| Q1 24 | $0.01 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $4.3M | $97.5M |
| 总债务越低越好 | $34.7M | $22.7M |
| 股东权益账面价值 | $45.7M | $130.3M |
| 总资产 | $209.2M | $216.3M |
| 负债/权益比越低杠杆越低 | 0.76× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资BRCCPBYI
| Q4 25 | $4.3M | $97.5M | ||
| Q3 25 | $9.5M | $94.4M | ||
| Q2 25 | $4.3M | $96.0M | ||
| Q1 25 | $3.9M | $93.2M | ||
| Q4 24 | $6.8M | $101.0M | ||
| Q3 24 | $7.3M | $96.7M | ||
| Q2 24 | $9.6M | $96.8M | ||
| Q1 24 | $4.0M | $107.2M |
总债务BRCCPBYI
| Q4 25 | $34.7M | $22.7M | ||
| Q3 25 | $35.0M | $34.0M | ||
| Q2 25 | $72.7M | $45.3M | ||
| Q1 25 | $68.8M | $56.7M | ||
| Q4 24 | $65.1M | $68.0M | ||
| Q3 24 | $64.9M | $79.3M | ||
| Q2 24 | $66.5M | $90.7M | ||
| Q1 24 | $61.5M | $102.0M |
股东权益BRCCPBYI
| Q4 25 | $45.7M | $130.3M | ||
| Q3 25 | $48.0M | $115.3M | ||
| Q2 25 | $10.1M | $104.7M | ||
| Q1 25 | $11.2M | $97.1M | ||
| Q4 24 | $13.2M | $92.1M | ||
| Q3 24 | $14.5M | $71.1M | ||
| Q2 24 | $14.9M | $48.5M | ||
| Q1 24 | $14.6M | $51.0M |
总资产BRCCPBYI
| Q4 25 | $209.2M | $216.3M | ||
| Q3 25 | $222.4M | $202.9M | ||
| Q2 25 | $225.3M | $194.9M | ||
| Q1 25 | $222.9M | $196.2M | ||
| Q4 24 | $227.4M | $213.3M | ||
| Q3 24 | $233.7M | $220.7M | ||
| Q2 24 | $229.9M | $205.0M | ||
| Q1 24 | $227.2M | $214.1M |
负债/权益比BRCCPBYI
| Q4 25 | 0.76× | 0.17× | ||
| Q3 25 | 0.73× | 0.30× | ||
| Q2 25 | 7.19× | 0.43× | ||
| Q1 25 | 6.15× | 0.58× | ||
| Q4 24 | 4.94× | 0.74× | ||
| Q3 24 | 4.47× | 1.12× | ||
| Q2 24 | 4.46× | 1.87× | ||
| Q1 24 | 4.21× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-8.7M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $-9.4M | $14.4M |
| 自由现金流率自由现金流/营收 | -8.3% | 19.1% |
| 资本支出强度资本支出/营收 | 0.6% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-13.5M | $41.7M |
8季度趋势，按日历期对齐
经营现金流BRCCPBYI
| Q4 25 | $-8.7M | $14.4M | ||
| Q3 25 | $6.4M | $9.7M | ||
| Q2 25 | $-3.3M | $14.1M | ||
| Q1 25 | $-4.1M | $3.6M | ||
| Q4 24 | $2.2M | $15.6M | ||
| Q3 24 | $1.9M | $11.0M | ||
| Q2 24 | $2.3M | $1.0M | ||
| Q1 24 | $4.9M | $11.2M |
自由现金流BRCCPBYI
| Q4 25 | $-9.4M | $14.4M | ||
| Q3 25 | $5.6M | $9.7M | ||
| Q2 25 | $-4.3M | $14.1M | ||
| Q1 25 | $-5.3M | $3.6M | ||
| Q4 24 | $504.0K | $15.6M | ||
| Q3 24 | $-205.0K | $11.0M | ||
| Q2 24 | $147.0K | $1.0M | ||
| Q1 24 | $2.2M | — |
自由现金流率BRCCPBYI
| Q4 25 | -8.3% | 19.1% | ||
| Q3 25 | 5.5% | 17.7% | ||
| Q2 25 | -4.5% | 26.8% | ||
| Q1 25 | -5.9% | 7.7% | ||
| Q4 24 | 0.5% | 26.4% | ||
| Q3 24 | -0.2% | 13.7% | ||
| Q2 24 | 0.2% | 2.1% | ||
| Q1 24 | 2.2% | — |
资本支出强度BRCCPBYI
| Q4 25 | 0.6% | 0.0% | ||
| Q3 25 | 0.8% | 0.0% | ||
| Q2 25 | 1.0% | 0.0% | ||
| Q1 25 | 1.3% | 0.1% | ||
| Q4 24 | 1.6% | 0.0% | ||
| Q3 24 | 2.2% | 0.0% | ||
| Q2 24 | 2.4% | 0.0% | ||
| Q1 24 | 2.8% | 0.0% |
现金转化率BRCCPBYI
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | 8.97× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BRCC
| Sales Channel Through Intermediary | $72.9M | 65% |
| Sales Channel Directly To Consumer | $34.4M | 31% |
| Outpost | $5.4M | 5% |
PBYI
暂无分部数据
